H. Lundbeck, Lundbeck files application for approval of Cipralex® for the treatment of generalised anxiety disorder

H. Lundbeck A/S has filed an application for approval of Cipralex® for the treatment of generalised anxiety disorder (GAD) in the EU with the health authorities in Sweden, which acts as reference country in the European mutual recognition procedure. Lundbeck expects to obtain approval from the European health authorities during 2005.